Life Sciences

Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.

Jul 1, 2026

PreOncology Launches AI-Based Early Cancer Detection Program

PreOncology has introduced a new oncologist-led medical specialty focused on preventing and detecting cancer before stage I, combining genomics, AI risk modeling, and personalized surveillance through its Stage Alpha Operating System.

Jul 1, 2026

LatusPet Publishes Study on AI Blood Test for Multi-Disease Screening in Dogs

LatusPet, a University of Oxford biotech startup, has published a peer-reviewed study demonstrating that its SINO platform can detect multiple diseases in dogs from a single blood sample with over 90% accuracy.

Jul 1, 2026

Caris Life Sciences Launches Multi Cancer Detection Blood Test Caris Detect

Caris Life Sciences has launched Caris Detect, a blood test that uses whole genome and transcriptome sequencing with artificial intelligence to identify early cancer signals across multiple cancer types.

Jun 30, 2026

One Brooklyn Health Selects hellocare.ai for AI Assisted Virtual Care Across Hospitals

One Brooklyn Health has chosen hellocare.ai to implement AI assisted virtual nursing and patient monitoring across its hospitals, introducing real time AI models for fall prevention and patient safety.

Jun 30, 2026

Ozelle to Present O-Cyte 1 Hematology Analyzer at ADLM 2026

Ozelle will debut its new automated hematology analyzer, O-Cyte 1, at ADLM 2026 in California. The system uses AI to deliver morphology intelligence and scalable throughput for clinical laboratories.

Jun 30, 2026

Xellar Biosystems Raises $50 Million to Expand 3D Bio Intelligence Platform

Xellar Biosystems has secured $50 million in Series A and A+ funding to advance its 3D Bio Intelligence platform that integrates organ-on-chip systems, automation, imaging, multi-omics, and AI modeling for drug discovery.

Jun 29, 2026

4DMedical Gains TGA Approval for CT:VQ Lung Imaging in Australia

4DMedical has received approval from the Australian Therapeutic Goods Administration for its CT:VQ imaging technology, enabling contrast-free ventilation and perfusion imaging using standard chest CT scans.

Jun 27, 2026

RADIN Health Expands Platform to Four More UHS Nevada Hospitals

RADIN Health has deployed its cloud-based radiology platform at four additional hospitals within the UHS Nevada Health System, bringing its total presence in the state to eight facilities.

Jun 26, 2026

UpDoc Receives FDA Clearance for Clinical AI Platform

UpDoc has received FDA clearance for its Software as a Medical Device, the first to use patient-facing large language models for clinical care delivery. The platform has also begun deployment at four major health systems and secured $18 million in seed funding.

Jun 26, 2026

Aidoc Receives FDA Breakthrough Designation for AI Radiology Report Drafting

Aidoc has received Breakthrough Device Designation from the U.S. Food and Drug Administration for its AI tool First Read, which generates preliminary radiology report text from chest radiographs to help reduce reporting time and support radiologists facing growing imaging demand.

Jun 26, 2026

Biolevate Integrates NVIDIA BioNeMo Toolkit for AI Drug Discovery

Biolevate is integrating NVIDIA BioNeMo Agent Toolkit and GPU-optimized pipelines into its OCEAN technology stack to enhance AI-based drug discovery workflows and improve RNA model predictions.

Jun 26, 2026

Upside Raises $20 Million Series A to Expand AI Supported Housing Platform for Healthcare

Upside has raised $20 million in a Series A round led by Aquiline Capital Partners and Flare Capital Partners to expand its AI supported housing stability platform for healthcare across the United States.

Jun 26, 2026

Clairyon AI Agent Shown to Improve Sepsis Care Compliance in JAMA Study

A study published in JAMA Network Open found that Clairyon's AI Clinical Abstraction Agent improved SEP-1 sepsis care compliance by 13 percent across two emergency departments.

Jun 26, 2026

Veeva Systems Introduces Veeva EHS for Environmental, Health, and Safety Management

Veeva Systems has launched Veeva EHS, a new application within its Veeva Quality Cloud platform, aimed at improving environmental, health, and safety management through real-time insights and intelligent automation. The application will be available to early adopters in August 2026.

Jun 26, 2026

DecisionDx-Melanoma Test Shows Greater Accuracy in Identifying Low-Risk Patients

A prospective study found that Castle Biosciences' DecisionDx-Melanoma i31-SLNB test more accurately identifies melanoma patients who may safely avoid sentinel lymph node biopsy compared to the Melanoma Institute Australia nomogram.

Jun 25, 2026

Chicago Pacific Founders Invests in Attune to Improve Healthcare Coordination

Attune has received a strategic growth investment from Chicago Pacific Founders to expand its healthcare engagement platform, which connects fragmented care systems and improves coordination across health plans and providers.

Jun 25, 2026

xCures Raises $46 Million Series B to Expand Clinical Clarity Platform

xCures has raised $46 million in Series B funding led by Innovius Capital. The financing will support the expansion of its platform that converts fragmented medical records into structured clinical data.

Jun 25, 2026

Children’s Hospital of Philadelphia Develops AI Tool to Guide Genetic Testing for Rare Diseases

Researchers at the Children's Hospital of Philadelphia have developed RareDAI, an AI tool that helps clinicians choose the most appropriate genetic tests for diagnosing rare diseases by following a structured chain of thought.

Jun 25, 2026

Sera Prognostics Joins ARPA-H Program to Develop Point of Care Birth Diagnostic

Sera Prognostics is collaborating with UC San Diego and Allegro MicroSystems on an ARPA-H funded project to create a point of care diagnostic test for fetal oxygen levels during labor.

Jun 24, 2026

Ascletis Pharma Receives FDA Clearance for Phase I Study of ASC35 Obesity Drug

Ascletis Pharma has received FDA Investigational New Drug clearance to begin a Phase I clinical trial of ASC35, a once-monthly subcutaneous dual peptide agonist for obesity treatment.

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.